EFG
SLS icon

Everhart Financial Group’s SELLAS Life Sciences SLS Stock Holding History

Everhart Financial Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Sell
288,018
-76,379
-21% -$527K 0.27% 49
2026
Q1 		$1.54M Sell
364,397
-101,819
-22% -$455K 0.13% 106
2025
Q4 		$1.76M Buy
466,216
+135,066
+41% +$263K 0.16% 81
2025
Q3 		$533K Buy
+331,150
New +$590K 0.05% 242

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Everhart Financial Group's SLS Position: Q2 2026 in Review

Everhart Financial Group reduced its SELLAS Life Sciences (SLS) stake by 21% in Q2 2026, selling an estimated $527K and leaving 288,018 shares worth $4.25M. The position accounts for 0.27% of the portfolio, ranked #49.

Everhart Financial Group first reported a position in SLS in Q3 2025 and has held it in 4 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Everhart Financial Group held 288,018 shares of SELLAS Life Sciences worth $4.25M as of Q2 2026.
  • Everhart Financial Group sold 76,379 SELLAS Life Sciences shares in Q2 2026, an estimated $527K.
  • SELLAS Life Sciences made up 0.27% of Everhart Financial Group's portfolio in Q2 2026, its #49 holding.
  • Everhart Financial Group first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.